Effects of Epitope Modification on T Cell Receptor–Ligand Binding and Antigen Recognition by Seven H-2Kd–restricted Cytotoxic T Lymphocyte Clones Specific for a Photoreactive Peptide Derivative

We tested for antigen recognition and T cell receptor (TCR)–ligand binding 12 peptide derivative variants on seven H-2Kd–restricted cytotoxic T lymphocytes (CTL) clones specific for a bifunctional photoreactive derivative of the Plasmodium berghei circumsporozoite peptide 252– 260 (SYIPSAEKI). The derivative contained iodo-4-azidosalicylic acid in place of PbCS S-252 and 4-azidobenzoic acid on PbCS K-259. Selective photoactivation of the N-terminal photoreactive group allowed crosslinking to Kd molecules and photoactivation of the orthogonal group to TCR. TCR photoaffinity labeling with covalent Kd–peptide derivative complexes allowed direct assessment of TCR–ligand binding on living CTL. In most cases (over 80%) cytotoxicity (chromium release) and TCR–ligand binding differed by less than fivefold. The exceptions included (a) partial TCR agonists (8 cases), for which antigen recognition was fivetenfold less efficient than TCR–ligand binding, (b) TCR antagonists (2 cases), which were not recognized and capable of inhibiting recognition of the wild-type conjugate, (c) heteroclitic agonists (2 cases), for which antigen recognition was more efficient than TCR–ligand binding, and (d) one partial TCR agonist, which activated only Fas (CD95), but not perforin/granzymemediated cytotoxicity. There was no correlation between these divergences and the avidity of TCR–ligand binding, indicating that other factors than binding avidity determine the nature of the CTL response. An unexpected and novel finding was that CD8-dependent clones clearly incline more to TCR antagonism than CD8-independent ones. As there was no correlation between CD8 dependence and the avidity of TCR–ligand binding, the possibility is suggested that CD8 plays a critical role in aberrant CTL function

THEMIS: A critical TCR signal regulator for ligand discrimination

10.1016/j.coi.2015.01.020Current Opinion in Immunology3386-9

Negative selection assay based on stimulation of T cell receptor transgenic thymocytes with peptide-MHC tetramers

10.1371/journal.pone.0043191PLoS ONE78e4319

The ups and downs of metabolism during the lifespan of a t cell

10.3390/ijms21217972International Journal of Molecular Sciences2121Jan-2

Taming the sentinels: Microbiome-derived metabolites and polarization of t cells

10.3390/ijms21207740International Journal of Molecular Sciences21201-1

Development of a screening strategy for new modulators of T cell receptor signaling and T cell activation

10.1038/s41598-018-28106-5Scientific Reports811004

A Dual Inhibitor of Cdc7/Cdk9 Potently Suppresses T Cell Activation

10.3389/fimmu.2019.01718Frontiers in immunology10171

CD40L expression allows CD8+ T cells to promote their own expansion and differentiation through dendritic cells

10.3389/fimmu.2017.01484Frontiers in Immunology8NOV148

Single cell analysis of drug susceptibility of mycobacterium abscessus during macrophage infection

10.3390/antibiotics9100711Antibiotics9101-1

Allelic exclusion of TCR �-chains upon severe restriction of V� repertoire

10.1371/journal.pone.0114320PLoS ONE912e11432